Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › OH › LOGAN › HOCKING VALLEY COMMUNITY HOSPITAL

HOCKING VALLEY COMMUNITY HOSPITAL

NPI: 1295840007 · LOGAN, OH 43138 · Critical Access Hospital · NPI assigned 08/20/2006

$13.74M
Total Medicaid Paid
324,774
Total Claims
271,089
Beneficiaries
197
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGROW, JULIE (CFO)
NPI Enumeration Date08/20/2006

Related Entities

Other providers sharing the same authorized official: GROW, JULIE

ProviderCityStateTotal Paid
HOCKING VALLEY COMMUNITY HOSPITAL LOGAN OH $1.16M
HOCKING VALLEY COMMUNITY HOSPITAL LOGAN OH $872.96

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 37,609 $1.16M
2019 37,768 $1.05M
2020 31,952 $1.22M
2021 38,108 $1.43M
2022 38,777 $1.73M
2023 79,002 $3.42M
2024 61,558 $3.72M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 22,938 20,537 $2.38M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 16,726 14,598 $1.64M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 15,070 14,345 $1.58M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 10,485 8,872 $1.19M
99284 Emergency department visit for the evaluation and management, high severity 7,142 6,420 $916K
99283 Emergency department visit for the evaluation and management, moderate severity 6,166 5,652 $783K
99215 Prolong outpt/office vis 3,506 2,995 $495K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 5,384 1,335 $449K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3,683 3,443 $444K
70450 Computed tomography, head or brain; without contrast material 1,354 1,101 $332K
64635 840 559 $273K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 2,641 937 $251K
74177 Computed tomography, abdomen and pelvis; with contrast material 715 590 $241K
64493 647 431 $234K
76000 2,885 2,383 $227K
74176 Computed tomography, abdomen and pelvis; without contrast material 727 623 $221K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1,677 1,524 $211K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,380 935 $195K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 566 335 $177K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,516 1,452 $154K
80053 Comprehensive metabolic panel 12,877 11,038 $116K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 858 672 $103K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 857 621 $92K
20610 512 339 $62K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2,573 2,400 $51K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 596 514 $51K
80048 Basic metabolic panel (calcium, ionized) 7,585 6,093 $46K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2,658 2,302 $41K
71046 Radiologic examination, chest; 2 views 1,389 1,223 $40K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 18,564 15,363 $39K
84443 Thyroid stimulating hormone (TSH) 1,755 1,535 $32K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2,398 2,283 $31K
97161 411 381 $28K
87400 3,496 3,136 $25K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 183 101 $24K
73630 731 613 $22K
36415 Collection of venous blood by venipuncture 23,687 19,534 $21K
80061 Lipid panel 1,401 1,278 $20K
84484 6,574 4,242 $19K
77063 Screening digital breast tomosynthesis, bilateral 284 270 $19K
97530 Therapeutic activities, direct patient contact, each 15 minutes 156 71 $18K
73562 535 465 $18K
83036 Hemoglobin; glycosylated (A1C) 1,323 1,204 $17K
76705 Ultrasound, abdominal, real time with image documentation; limited 122 108 $15K
72125 Computed tomography, cervical spine; without contrast material 284 213 $15K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 699 633 $14K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 84 68 $14K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 5,681 4,998 $14K
80306 2,482 2,101 $14K
73030 471 395 $12K
73110 438 341 $12K
84439 484 435 $12K
73610 517 429 $12K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 8,837 7,304 $11K
71045 Radiologic examination, chest; single view 6,231 5,184 $11K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 167 39 $11K
87088 3,917 3,355 $11K
74018 204 174 $10K
71250 99 84 $10K
80348 1,140 1,060 $10K
73130 558 449 $9K
20552 78 66 $8K
77067 Screening mammography, bilateral, including computer-aided detection 285 271 $7K
82728 299 277 $7K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 908 809 $6K
82607 265 242 $6K
80362 1,136 1,058 $6K
80076 886 705 $5K
83735 6,307 4,920 $5K
87430 7,391 6,801 $5K
87070 354 312 $5K
81001 8,783 7,697 $5K
71275 Computed tomographic angiography, chest, with contrast material 19 13 $4K
94060 30 25 $4K
64640 13 13 $4K
64494 639 426 $4K
83540 351 319 $4K
80346 222 206 $4K
86140 202 174 $3K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 149 135 $3K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 29 12 $3K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2,863 1,869 $3K
87077 844 659 $3K
J3490 Unclassified drugs 1,916 1,093 $3K
85610 5,072 4,322 $3K
64454 27 12 $3K
72100 108 101 $3K
83992 651 637 $3K
85027 1,055 789 $2K
80324 651 637 $2K
12001 13 12 $2K
85007 835 622 $2K
73502 58 54 $2K
83550 193 174 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 149 135 $2K
87186 733 567 $2K
80361 697 679 $2K
83690 1,952 1,604 $1K
85652 291 248 $1K
G0378 Hospital observation service, per hour 29 12 $1K
80365 679 659 $1K
82570 118 106 $1K
85730 4,534 3,806 $1K
99205 Prolong outpt/office vis 22 12 $1K
81025 2,092 1,733 $1K
80354 651 637 $1K
80347 651 637 $1K
80373 654 638 $1K
80356 651 637 $1K
80360 650 636 $1K
80353 651 637 $1K
80368 651 637 $1K
80355 652 637 $1K
80366 651 637 $1K
80370 650 636 $1K
80372 651 637 $1K
80358 651 637 $1K
80359 651 637 $1K
64636 838 556 $1K
72110 15 12 $1K
80320 82 77 $852.16
86703 33 26 $838.32
83605 855 564 $834.41
83880 503 404 $807.70
73560 14 12 $741.36
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel 16 16 $723.92
99156 431 354 $713.70
85379 477 386 $711.19
73080 33 26 $700.96
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 53 47 $638.77
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 237 166 $623.84
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 4,666 3,842 $596.93
80069 28 26 $583.22
82746 64 61 $564.05
88305 Level IV - Surgical pathology, gross and microscopic examination 72 30 $504.38
83970 16 12 $498.83
96376 428 295 $469.99
96375 Therapeutic injection; each additional sequential IV push 3,431 2,740 $395.15
80329 68 38 $382.51
87040 377 167 $346.82
86900 19 13 $345.60
83655 12 12 $332.05
82043 57 48 $320.99
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 438 358 $312.49
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 109 84 $303.01
80377 33 28 $236.19
84403 14 13 $232.18
82565 17 13 $202.73
84702 14 12 $180.61
J1170 Injection, hydromorphone, up to 4 mg 148 94 $176.53
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 627 475 $144.50
87899 32 25 $140.13
94760 7,720 6,497 $130.50
84703 95 80 $113.29
J7030 Infusion, normal saline solution , 1000 cc 3,648 2,830 $113.27
87420 21 15 $112.58
74022 14 12 $107.84
73090 14 13 $94.35
85018 14 12 $75.57
82550 100 81 $59.69
81003 140 124 $57.85
J1885 Injection, ketorolac tromethamine, per 15 mg 981 756 $54.89
J2270 Injection, morphine sulfate, up to 10 mg 132 90 $42.89
J2704 Injection, propofol, 10 mg 404 320 $39.66
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,114 802 $33.27
82800 30 24 $31.84
86901 20 14 $26.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 109 89 $17.51
J1030 Injection, methylprednisolone acetate, 40 mg 385 300 $12.51
J3010 Injection, fentanyl citrate, 0.1 mg 170 130 $8.75
J3475 Injection, magnesium sulfate, per 500 mg 35 24 $6.08
J0690 Injection, cefazolin sodium, 500 mg 14 12 $3.48
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 180 116 $3.01
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 108 83 $2.63
J2765 Injection, metoclopramide hcl, up to 10 mg 60 55 $2.18
J2919 Injection, methylprednisolone sodium succinate, 5 mg 33 26 $2.16
J2003 Injection, lidocaine hydrochloride, 1 mg 105 85 $1.39
J2250 Injection, midazolam hydrochloride, per 1 mg 15 12 $1.30
J1100 Injection, dexamethasone sodium phosphate, 1 mg 40 27 $1.30
J7050 Infusion, normal saline solution, 250 cc 56 38 $0.65
76377 414 297 $0.00
82150 27 26 $0.00
94762 173 146 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 31 28 $0.00
51798 13 12 $0.00
94761 36 28 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 42 28 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 33 26 $0.00
36000 55 24 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,418 1,155 $0.00
99152 81 73 $0.00
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 13 13 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 54 25 $0.00
76376 63 53 $0.00
51702 14 12 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 20 13 $0.00
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 14 13 $0.00